Meeting
2022 ASCO Annual Meeting
Persistent high-risk opioid use in lymphoma survivors following treatment.
Authors
Katherine Ann Stafford
Mount Auburn Hospital, Cambridge, MA
Katherine Ann Stafford , Anita J. Kumar , Virginia Pate , Alison W. Loren , Alan Kinlaw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 6585)
DOI
10.1200/JCO.2022.40.16_suppl.6585
Abstract #
6585
Poster Bd #
367
Abstract Disclosures
Similar Posters
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Changes in opioid type and dose among cancer patients referred to outpatient palliative care.
First Author: Ali Haider
Poster
2023 ASCO Quality Care Symposium
Outpatient versus inpatient delivery of intensive chemotherapy for patients with hematological neoplasms: A 5-year experience from a tertiary center.
First Author: Luluh Bin Dayil
Poster
2022 ASCO Quality Care Symposium
The association between medical cannabis and prescription opioid medication use in patients with early-stage cancer: A population-based study.
First Author: Safiya Karim
Poster
2020 ASCO Virtual Scientific Program
National estimates of substance use, substance use disorders, and treatment among adolescent and young adult cancer survivors.
First Author: Xu Ji